In early September a draft bill prepared by the Federal Ministry of Finance to update the tax loss carry-forward rules for corporations was made available to BIO Deutschland for comments.
On 20 September, BIO Deutschland held an information evening to discuss the topics of personalised medicine and advanced therapy medicinal products (ATMPs) with members of the Bundestag.
On 8 September the Working Group on Industrial Cell Technology met in Lübeck prior to the start of the Industrial Cell Technology Symposium, organised by the Fraunhofer Research Institution for Marine Biotechnology (EMB).
In mid-September the constituent meeting of the Legal Working Group of BIO Deutschland’s European partner EUCOPE was held in Berlin. BIO Deutschland was represented at the meeting by a representative from its office.